Fosun Pharma: Progress in asset disposal planning Special fund actual contribution of 30 million yuan

Fosun Pharmaceutical announced that as of the date of this announcement, the special fund has completed the industrial and commercial registration and has received a total of RMB 30 million in first-phase paid-in capital from all partners, and is still awaiting the completion of the record filing with the China Securities Investment Fund Association. On March 24, 2026, the relevant parties signed a "Supplementary Agreement" to the "Framework Agreement," agreeing to adjust the latest date for signing the "Transfer Agreement" to September 30, 2026.